Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H23NO4 |
Molecular Weight | 329.3902 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C4C(C[C@H]5N(CC=C)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O
InChI
InChIKey=HMWHERQFMBEHNG-AQQQZIQISA-N
InChI=1S/C19H23NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,13-14,17,21-23H,1,5-10H2/t13-,14+,17-,18-,19+/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11413242Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
6-alpha-Naloxol is active metabolite of naloxone. 6-alpha-Naloxol was shown to be neutral antagonist at the mu receptor in vitro, with no affect on cAMP levels or GTPitalic gammaS binding, regardless of morphine pretreatment. It elicits withdrawal behaviour and conditioned place aversion in morphine pretreated rodents.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
Curator's Comment: 6-alpha-Naloxol is CNS active in animals. No human data available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL233 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242 |
0.63 nM [Ki] | ||
Target ID: CHEMBL236 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242 |
2.1 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15956992
rats: 0.05–100 mg/kg, s.c.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20942579
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
5492271
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
Naloxol
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
m11769
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
300000013056
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
20410-95-1
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
FLW43Q2H9L
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY |
PARENT (METABOLITE LESS ACTIVE)
SUBSTANCE RECORD